Notice of Compliance Information

From Health Canada

Notice of Compliance date :
2024-11-25
Manufacturer :
NOVO NORDISK CANADA INC
Product type:
Biologic
NOC with conditions:
No
Submission type:
Supplement to a New Drug Submission (SNDS)
Reason for supplement:
New Indication: to reduce the risk of non-fatal myocardial infarction in adults with established cardiovascular disease and BMI equal to or greater than 27 kg/m2
Submission class:
Other

Brand  1  of 1 :

WEGOVY

Product 1 of 11 :

Drug identification number:  00000N/A
Dosage form(s): Solution
Route(s) of administration: Subcutaneous
Medicinal ingredient(s):
This table displays medicinal ingredients information.
Ingredient Strength
SEMAGLUTIDE 2 MG/3ML

Product 2 of 11 :

Drug identification number:  00000N/A
Dosage form(s): Solution
Route(s) of administration: Subcutaneous
Medicinal ingredient(s):
This table displays medicinal ingredients information.
Ingredient Strength
SEMAGLUTIDE 0.5 MG/0.5ML

Product 3 of 11 :

Drug identification number:  00000N/A
Dosage form(s): Solution
Route(s) of administration: Subcutaneous
Medicinal ingredient(s):
This table displays medicinal ingredients information.
Ingredient Strength
SEMAGLUTIDE 2.4 MG/0.75ML

Product 4 of 11 :

Drug identification number:  00000N/A
Dosage form(s): Solution
Route(s) of administration: Subcutaneous
Medicinal ingredient(s):
This table displays medicinal ingredients information.
Ingredient Strength
SEMAGLUTIDE 1 MG/1.5ML

Product 5 of 11 :

Drug identification number:  00000N/A
Dosage form(s): Solution
Route(s) of administration: Subcutaneous
Medicinal ingredient(s):
This table displays medicinal ingredients information.
Ingredient Strength
SEMAGLUTIDE 2 MG/1.5ML

Product 6 of 11 :

Drug identification number:  00000N/A
Dosage form(s): Solution
Route(s) of administration: Subcutaneous
Medicinal ingredient(s):
This table displays medicinal ingredients information.
Ingredient Strength
SEMAGLUTIDE 9.6 MG/3ML

Product 7 of 11 :

Drug identification number:  00000N/A
Dosage form(s): Solution
Route(s) of administration: Subcutaneous
Medicinal ingredient(s):
This table displays medicinal ingredients information.
Ingredient Strength
SEMAGLUTIDE 1 MG/0.5ML

Product 8 of 11 :

Drug identification number:  00000N/A
Dosage form(s): Solution
Route(s) of administration: Subcutaneous
Medicinal ingredient(s):
This table displays medicinal ingredients information.
Ingredient Strength
SEMAGLUTIDE 6.8 MG/3ML

Product 9 of 11 :

Drug identification number:  00000N/A
Dosage form(s): Solution
Route(s) of administration: Subcutaneous
Medicinal ingredient(s):
This table displays medicinal ingredients information.
Ingredient Strength
SEMAGLUTIDE 4 MG/3ML

Product 10 of 11 :

Drug identification number:  00000N/A
Dosage form(s): Solution
Route(s) of administration: Subcutaneous
Medicinal ingredient(s):
This table displays medicinal ingredients information.
Ingredient Strength
SEMAGLUTIDE 1.7 MG/0.75ML

Product 11 of 11 :

Drug identification number:  00000N/A
Dosage form(s): Solution
Route(s) of administration: Subcutaneous
Medicinal ingredient(s):
This table displays medicinal ingredients information.
Ingredient Strength
SEMAGLUTIDE 0.25 MG/0.5ML

New search



Date modified: